HIGHLIGHTS
- who: Brigit M. Aarts from the Department of, The Netherlands Cancer Institute, Department of, Amsterdam University Medical Center have published the paper: Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysis, in the Journal: (JOURNAL)
- what: The aim of this study was to compare the safety and efficacy of and for the treatment of Methods Patients with T1a treated by or in two referral centers were retrospectively analyzed.
- how: The results are in line with the current literature showing no difference between RFA and MWA for . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.